CCL2 as a trigger of manifestations of compensatory anti-inflammatory response syndrome in mice with severe systemic inflammatory response syndrome

Journal of Leukocyte Biology

Volumn 79, Issue 4, 2006, Pages 789-796

  Takahashi, Hitoshi ^a   Tsuda, Yasuhiro ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

CARS; Neutrophils; SIRS

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, MOUSE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; COMPENSATORY ANTI INFLAMMATORY RESPONSE SYNDROME; CONTROLLED STUDY; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; COCULTURE; COMPARATIVE STUDY; DISEASE MODEL; IMMUNE DEFICIENCY; IMMUNOLOGY; KINETICS; TIME;

MURINAE;

ANIMALS; CHEMOKINE CCL2; COCULTURE TECHNIQUES; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOLOGIC DEFICIENCY SYNDROMES; KINETICS; MICE; MICE, INBRED BALB C; NEUTROPHILS; PANCREATITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; TIME FACTORS;

EID: 33746414863     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0705372     Document Type: Article

References (55)

1. Riedemann, N. C., Guo, R. F., Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524.
2. Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J. L., Ramsay, G. (2003) 2001 SCCM/ESICM/ACCP/SIS International Sepsis Definition Conference. Intensive Care Med. 29, 530-538.
3. (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20, 864-874.
4. Takala, A., Jousela, I., Olkkola, K. T., Jansson, S. E., Leirisalo-Repo, M., Takkunen, O., Repo, H. (1999) Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients administered to hospital in a medical emergency. Clin. Sci. 96, 287-295.
5. Duflo, F., Debon, R., Monneret, G., Bienvenu, J., Chassard, D., Allaouchiche, B. (2002) Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 96, 74-79.
6. Petrak, R. A., Balk, R. A., Bone, R. C. (1989) Prostaglandins, cyclooxygenase inhibitors, and thromboxane synthesis inhibitors in the pathogenesis of multiple organ failure. Crit. Care Clin. 5, 303-314.
7. Lewis, R. A., Austen, K. F., Soberman, R. J. (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323, 645-655.
8. Levi, M., ten Cate, H., van der Poll, T., van Deventer, S. J. (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270, 975-979.
9. Gomez-Jimenez, J., Salgado, A., Mourelle, M. (1995) Nitric oxide pathway in endotoxemia and human septic shock. Crit. Care Med. 23, 253-258.
10. Miyauchi, T., Tomobe, Y., Shiba, R. (1990) Improvement of endothelin in the regulation of human vascular tonus. Circulation 81, 1874-1880.
11. Miller-Graziano, C. L., Szabo, G., Kodys, K., Griffey, K. (1990) Aberrations in post-trauma monocytes (Mφ) subpopulation: role in septic shock syndrome. J. Trauma 30, S86-S96.
12. Bellingan, G. (1999) Inflammatory cell activation in sepsis. Br. Med. Bull. 55, 12-29.
13. Bone, R. C. (1996) Immunological dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125, 680-687.
14. Bone, R. C. (1997) Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. In Sepsis and Multiorgan Failure (A. M. Fein, E. M. Abraham, R. A. Balk, G. R. Bernard, R. C. Bone, D. R. Dantzker, M. P. Fink, eds.), Philadelphia, PA, Williams & Wilkins, 3-10.
15. Foex, B. A. (1999) Systemic responses to trauma. Br. Med. Bull. 55, 726-743.
16. Piper, R. D., Sibbald, W. J. (1997) Multiple organ dysfunction syndrome. The relevance of persistent infection and inflammation. In Sepsis and Multiorgan Failure (A. M. Fein, E. M. Abraham, R. A. Balk, G. R. Bernard, R. C. Bone, D. R. Dantzker, M. P. Fink, eds.), Philadelphia, PA, Williams & Wilkins, 189-208.
17. Bone, R. C. (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24, 1125-1128.
18. Kox, W. J., Bone, R. C., Krausch, D., Docke, W. D., Kox, S. N., Wauer, H., Egerer, K., Querner, S., Asadullah, K., von Baehr, R., Volk, H. D. (1997) Interferon γ-1b in the treatment of conpensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch. Intern. Med. 157, 389-393.
19. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D., Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3, 678-681.
20. Volk, H. D., Reinke, P., Docke, W. D. (2000) Clinical aspects: from systemic inflammation to "immunoparalysis". Chem. Immunol. 74, 162-177.
21. Del Prete, G., Romagnani, S. (1994) The role of Th1 and Th2 subsets in human infectious diseases. Trends Microbiol. 2, 4-6.
22. Romagnani, S. (1996) Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 4, 470-473.
23. Cenci, E., Perito, S., Enssle, K. H., Mosci, P., Latge, J. P., Romani, L., Bistoni, F. (1997) Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 65, 564-570.
24. + type 2 T cells. J. Leukoc. Biol. 63, 723-731.
25. Shimizu, T., Shiratori, K., Sawada, T., Kobayashi, M., Hayashi, N., Saotome, H., Keith, J. C. (2000) Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 21, 134-140.
26. Van Laethem, J. L., Marchant, A., Delvaux, A., Goldman, M., Robberecht, P., Velu, T., Deviere, J. (1995) Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108, 1917-1922.
27. Kobayashi, H., Kobayashi, M., Utsunomiya, T., Herndon, D. N., Pollard, R. B., Suzuki, F. (1999) Therapeutic protective effect of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J. Immunol. 162, 7148-7154.
28. Takahashi, H., Tashiro, T., Miyazaki, M., Kobayashi, M., Pollard, R. B., Suzuki, F. (2002) An essential role of macrophage inflammatory protein 1α/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukoc. Biol. 72, 1190-1197.
29. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., Suzuki, F. (2004) Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21, 215-226.
30. Kishimoto, T. K., Jutila, M. A., Berg, E. L., Butcher, E. C. (1989) Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245, 1238-1241.
31. Jacobson, P. B., Schrier, D. J. (1993) Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2. J. Immunol. 151, 5639-5652.
32. 2) in human neutrophils. J. Clin. Invest. 92, 1467-1476.
33. Hansch, G. M., Wagner, C. (2003) Expression of MHC class II antigen and coreceptor molecules in polymorphonuclear neutrophils. Chem. Immunol. Allergy 83, 45-63.
34. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., Suzuki, F. (2004) CCL2, a product of mice early after systemic inflammatory response syndrome (SIRS), induces alternatively activated macrophages capable of impairing antibacterial resistance of SIRS mice. J. Leukoc. Biol. 76, 368-373.
35. Takahashi, H., Kobayashi, M., Tsuda, Y., Herndon, D. N., Suzuki, F. (2005) Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. Cytokine 29, 208-214.
36. Furukawa, K., Kobayashi, M., Herndon, D. N., Pollard, R. B., Suzuki, F. (2002) Appearance of MCP-1 early after thermal injury: a role on the subsequent development of burn-associated type 2 T cell responses. Ann. Surg. 236, 112-119.
37. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., Rollins, B. J. (2000) Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411.
38. 2. Proc. Natl. Acad. Sci. USA 86, 3803-3809.
39. Colotta, F., Re, F., Muzio, M., Polentarutti, N., Minty, A., Caput, D., Ferrara, P., Mantovani, A. (1994) Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269, 12403-12409.
40. De Vries, J. E. (1996) Molecular and biological characteristics of interleukin-13. Chem. Immunol. 63, 204-218.
41. Doughty, L., Carcillo, J. A., Kaplan, S., Janosky, J. (1998) The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 113, 1625-1631.
42. Lyons, A., Kelly, J. L., Rodrick, M. L., Mannick, J. A., Lederer, J. A. (1997) Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann. Surg. 226, 450-460.
43. Barlow, Y. (1994) T lymphocytes and immunosuppression in the burned patient: a review. Burns 20, 487-490.
44. O'Sullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H., Mannick, J. A., Rodrick, M. L. (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222, 482-492.
45. Decker, D., Schondorf, M., Bidlingmaier, F., Hirner, A., von Ruecker, A. A. (1996) Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119, 316-325.
46. + myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169, 3180-3190.
47. Schwartz, C. J., Valente, A. J., Sprague, E. A., Kelley, J. L., Nerem, R. M. (1991) The pathogenesis of atherosclerosis: an overview. Clin. Cardiol. 14 (Suppl. 1), I1-16.
48. Sozzani, S., Introna, M., Bernasconi, S., Polentarutti, N., Cinque, P., Poli, G., Sica, A., Mantovani, A. (1997) MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J. Leukoc. Biol. 62, 30-33.
49. Mazzucchelli, L., Loetscher, P., Kappeler, A., Uguccioni, M., Baggiolini, M., Laissue, J. A., Mueller, C. (1996) Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am. J. Pathol. 149, 501-509.
50. Boring, L., Charo, I. F., Rollinss, B. J. (1999) MCP-1 in human disease. In Chemokines in Disease (C. A. Hebert, ed.), Totowa, NJ, Humana, 53-65.
51. Nakajima, H., Kobayashi, M., Pollard, R. B., Suzuki, F. (2001) Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating of Th2 responses. J. Leukoc. Biol. 70, 374-380.
52. Furukawa, K., Kobayashi, M., Sasaki, H., Herndon, D. N., Pollard, R. B., Suzuki, F. (2002) Cryptococcal encephalitis demonstrated in thermally injured mice is accelerated by type 2 T cell responses. Crit. Care Med. 30, 1419-1424.
53. Goerdt, S., Orfanos, C. E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
54. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
55. Katakura, T., Miyazaki, M., Kobayashi, M., Herndon, D. N., Suzuki, F. (2004) CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172, 1407-1413.